Evidence map›Paper›PMID 28747380›Full record

ArticleMolecular & cellular proteomics : MCP2017

Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.

Malgorzata A Komor, Thang V Pham, Annemieke C Hiemstra, Sander R Piersma, Anne S Bolijn, Tim Schelfhorst, Pien M Delis-van Diemen, Marianne Tijssen, Robert P Sebra, Meredith Ashby and 3 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Integrative Proteogenomics Using ProteomeGenerator2.Journal of proteome research · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Nuclear Receptors and Lipid Sensing.Advances in experimental medicine and biology · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Malgorzata A KomorFrom the ‡Translational Gastrointestinal Oncology, Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0002-2983-1639
Thang V Pham§Oncoproteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Annemieke C HiemstraFrom the ‡Translational Gastrointestinal Oncology, Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Sander R Piersma§Oncoproteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Anne S BolijnFrom the ‡Translational Gastrointestinal Oncology, Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Tim Schelfhorst§Oncoproteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Pien M Delis-van DiemenFrom the ‡Translational Gastrointestinal Oncology, Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Marianne TijssenFrom the ‡Translational Gastrointestinal Oncology, Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Robert P Sebra¶School of Medicine at Mount Sinai, Institute for Genomics and Multiscale Biology, New York, New York.
Meredith Ashby‖Pacific Biosciences, Menlo Park, California.
Gerrit A MeijerFrom the ‡Translational Gastrointestinal Oncology, Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Connie R Jimenez§Oncoproteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Remond J A FijnemanFrom the ‡Translational Gastrointestinal Oncology, Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; R.Fijneman@nki.nl.ORCID 0000-0003-2076-5521

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteogenomics,

Indexed as

Alternative SplicingBiomarkers, TumorCell Line, TumorColorectal NeoplasmsHumansPhosphoproteinsProtein ConformationProtein IsoformsProteogenomicsProteomeRNA SplicingRNA Splicing FactorsSequence Analysis, RNASerine-Arginine Splicing FactorsBiomarkers, TumorPhosphoproteinsProtein IsoformsProteomeRNA Splicing FactorsSerine-Arginine Splicing FactorsSF3B1 protein, humanSRSF1 protein, human

Identifiers

PMID28747380
PMCPMC5629268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.